1994 - Fellow of the American Association for the Advancement of Science (AAAS)
1976 - Fellow of John Simon Guggenheim Memorial Foundation
Theodore Friedmann focuses on Molecular biology, Genetic enhancement, Genetics, Virology and Gene. His Molecular biology study incorporates themes from Cell culture, Retrovirus, Viral replication and Hypoxanthine-guanine phosphoribosyltransferase, Hypoxanthine Phosphoribosyltransferase. The concepts of his Genetic enhancement study are interwoven with issues in Bioinformatics, Psychotherapist, Viral vector, Disease and Computational biology.
His studies examine the connections between Virology and genetics, as well as such issues in Vector, with regards to Titer. In his research, Zebrafish is intimately related to Transgene, which falls under the overarching field of Virus. His Genetic transfer research includes elements of Molecular genetics and Somatic cell.
His primary areas of investigation include Molecular biology, Genetic enhancement, Gene, Genetics and Virology. He interconnects Hypoxanthine-guanine phosphoribosyltransferase, Mutant, Transfection and Virus, Vesicular stomatitis virus in the investigation of issues within Molecular biology. Theodore Friedmann focuses mostly in the field of Genetic enhancement, narrowing it down to topics relating to Gene transfer and, in certain cases, Engineering ethics.
His study in Gene expression, Reporter gene, Phenotype, Plasmid and Genetically modified organism are all subfields of Gene. His Virology research incorporates themes from Vector and Viral vector. His Retrovirus research includes themes of Viral envelope, Transduction and Cell biology.
His scientific interests lie mostly in Genetic enhancement, Hypoxanthine-guanine phosphoribosyltransferase, Bioinformatics, Disease and Genetics. His Genetic enhancement research is multidisciplinary, incorporating elements of Vector, Gene transfer and Leukemia. His work deals with themes such as Virus, Neutralizing antibody, Transfection and Glycoprotein, which intersect with Vector.
His Hypoxanthine-guanine phosphoribosyltransferase research is classified as research in Gene. His work in Genetics is not limited to one particular discipline; it also encompasses Computational biology. He has researched Genetic therapy in several fields, including Human genome, Virology, Metabolic disease, Viral vector and Genome editing.
His primary scientific interests are in Cell biology, Hypoxanthine-guanine phosphoribosyltransferase, Molecular biology, Gene knockdown and Engineering ethics. His Hypoxanthine-guanine phosphoribosyltransferase study falls within the topics of Gene and Genetics. His research in Gene tackles topics such as Dopaminergic which are related to areas like Cancer research.
His work on Neurogenesis and SOX2 as part of his general Genetics study is frequently connected to Platelet activation, thereby bridging the divide between different branches of science. His biological study spans a wide range of topics, including RNA and DNA. His Engineering ethics research also works with subjects such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
Jane C. Burns;Theodore Friedmann;Wolfgang Driever;Michelle Burrascano.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
Huei-Jen Su Huang;Jiing-Kuan Yee;Jin-Yuh Shew;Phang-Lang Chen.
Science (1988)
Progress toward human gene therapy
Theodore Friedmann.
Science (1989)
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes
Jiing-Kuan Yee;Atsushi Miyanohara;Patricia Laporte;Kathy Bouic.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Gene Therapy for Human Genetic Disease
Theodore Friedmann;Richard Roblin.
Science (1972)
Generation of high-titer pseudotyped retroviral vectors with very broad host range.
Jiing-Kuan Yee;Theodore Friedmann;Jane C. Burns.
Methods in Cell Biology (1994)
Base sequence studies of 300 nucleotide renatured repeated human DNA clones
Prescott L. Deininger;Douglas J. Jolly;Carol M. Rubin;Theodore Friedmann.
Journal of Molecular Biology (1981)
Advances in genetics
M. Demerec;Ernst W. Caspari;J. M. Thoday;John G. Scandalios.
Advances in Genetics (1947)
Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression
Michael B. Rosenberg;Theodore Friedmann;Robin C. Robertson;Mark Tuszynski.
Science (1988)
Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence.
Mark Schumacher;Shelley Camp;Yves Maulet;Michael Newton.
Nature (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Salk Institute for Biological Studies
Tulane University
University of California, San Diego
Salk Institute for Biological Studies
University of California, San Diego
Harvard University
University of Wisconsin–Madison
University of California, San Diego
University of California, Davis
Eli Lilly (United States)
University of Florida
Indian Institute of Technology Madras
Jiangsu University
Institute of Chemical Technology
Brown University
Colorado School of Mines
Oak Ridge National Laboratory
University of Miami
Boston Children's Hospital
University of Turin
University of Waterloo
Indiana University
Federal University of Rio Grande do Sul
University of California, Los Angeles
Sunnybrook Health Science Centre
Stanford University